[go: up one dir, main page]

FR2369845A1 - Excessive tobacco consumption treatment compsn. - contains capsicum, aconite, ballota, crataegus, drosera, grindelia, lobelia, passion flower and white willow - Google Patents

Excessive tobacco consumption treatment compsn. - contains capsicum, aconite, ballota, crataegus, drosera, grindelia, lobelia, passion flower and white willow

Info

Publication number
FR2369845A1
FR2369845A1 FR7633804A FR7633804A FR2369845A1 FR 2369845 A1 FR2369845 A1 FR 2369845A1 FR 7633804 A FR7633804 A FR 7633804A FR 7633804 A FR7633804 A FR 7633804A FR 2369845 A1 FR2369845 A1 FR 2369845A1
Authority
FR
France
Prior art keywords
ballota
grindelia
drosera
lobelia
aconite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7633804A
Other languages
French (fr)
Other versions
FR2369845B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCHLICKLIN JEAN MARIE
Original Assignee
SCHLICKLIN JEAN MARIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCHLICKLIN JEAN MARIE filed Critical SCHLICKLIN JEAN MARIE
Priority to FR7633804A priority Critical patent/FR2369845A1/en
Publication of FR2369845A1 publication Critical patent/FR2369845A1/en
Application granted granted Critical
Publication of FR2369845B1 publication Critical patent/FR2369845B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Elle comprend l'association en proportion déterminée de neuf substances végétales dont l'action est synergique. Elle doit être administrée exclusivement par voie orale et peut être préparée sous diverses présentations liquides et solides. Son utilisation permet de rendre désagréable l'arôme du tabac au point d'en entraîner l'arrêt immédiat; - de substituer un alcaloïde non toxique et dépourvu d'effet d'accoutumance à la nicotine; - de combattre la sensation de manque et les troubles de l'humeur observés fréquemment au début du sevrage.It includes the association in determined proportion of nine plant substances whose action is synergistic. It should be administered exclusively orally and can be prepared in various liquid and solid presentations. Its use makes it possible to make the aroma of tobacco unpleasant to the point of immediately stopping it; - to substitute a non-toxic alkaloid with no nicotine addictive effect; - to combat the feeling of withdrawal and mood disorders frequently observed at the start of weaning.

FR7633804A 1976-11-03 1976-11-03 Excessive tobacco consumption treatment compsn. - contains capsicum, aconite, ballota, crataegus, drosera, grindelia, lobelia, passion flower and white willow Granted FR2369845A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7633804A FR2369845A1 (en) 1976-11-03 1976-11-03 Excessive tobacco consumption treatment compsn. - contains capsicum, aconite, ballota, crataegus, drosera, grindelia, lobelia, passion flower and white willow

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7633804A FR2369845A1 (en) 1976-11-03 1976-11-03 Excessive tobacco consumption treatment compsn. - contains capsicum, aconite, ballota, crataegus, drosera, grindelia, lobelia, passion flower and white willow

Publications (2)

Publication Number Publication Date
FR2369845A1 true FR2369845A1 (en) 1978-06-02
FR2369845B1 FR2369845B1 (en) 1979-03-02

Family

ID=9179712

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7633804A Granted FR2369845A1 (en) 1976-11-03 1976-11-03 Excessive tobacco consumption treatment compsn. - contains capsicum, aconite, ballota, crataegus, drosera, grindelia, lobelia, passion flower and white willow

Country Status (1)

Country Link
FR (1) FR2369845A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423030A (en) * 1981-05-13 1983-12-27 Colgate-Palmolive Company Flavored aqueous oral composition
US5414005A (en) * 1993-10-28 1995-05-09 Dynagen, Inc. Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation
GB2289204A (en) * 1994-04-21 1995-11-15 Williamson Research Limited A chewing gum for use as a nicotine substitute and slimming aid
US5780051A (en) * 1992-04-02 1998-07-14 Dynagen, Inc. Methods and articles of manufacture for nicotine cessation and monitoring nicotine use
WO2002066041A1 (en) * 2001-02-23 2002-08-29 Herbal Detox Therapy Aps Natural composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423030A (en) * 1981-05-13 1983-12-27 Colgate-Palmolive Company Flavored aqueous oral composition
US5780051A (en) * 1992-04-02 1998-07-14 Dynagen, Inc. Methods and articles of manufacture for nicotine cessation and monitoring nicotine use
US5414005A (en) * 1993-10-28 1995-05-09 Dynagen, Inc. Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation
GB2289204A (en) * 1994-04-21 1995-11-15 Williamson Research Limited A chewing gum for use as a nicotine substitute and slimming aid
GB2289204B (en) * 1994-04-21 1998-01-14 Williamson Research Limited A chewing gum for use as a nicotine substitute and slimming aid
WO2002066041A1 (en) * 2001-02-23 2002-08-29 Herbal Detox Therapy Aps Natural composition

Also Published As

Publication number Publication date
FR2369845B1 (en) 1979-03-02

Similar Documents

Publication Publication Date Title
Russell et al. Clinical use of nicotine chewing-gum.
HENNINGFIELD Behavioral pharmacology of cigarette smoking
Campbell et al. Transdermal nicotine plus support in patients attending hospital with smoking-related diseases: a placebo-controlled study
US3789840A (en) Device for assisting cigarette smokers to discontinue smoking
RU94040387A (en) Nicotine-containing composition
Schüller et al. Transplacental induction of pancreas tumors in hamsters by ethanol and the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
ATE226080T1 (en) REGULATING HUMAN PLATELET REACTIVITY BY ADMINISTRATION OF SPORT PINE EXTRACT (PYCNOGENOL TM)
Bobo et al. Nicotine addiction counseling for chemically dependent patients.
EP0674511A1 (en) ANTIPYRETIC AND ANALGETIC METHODS AND COMPOSITIONS CONTAINING OPTICALLY PURE R-KETOROLAC.
ATE388687T1 (en) MEDICINAL ADMINISTRATION OF NICOTINE IN THE FORM OF CHEWING GUM
CA2271162A1 (en) Stearidonic acid compositions and uses thereof
FR2369845A1 (en) Excessive tobacco consumption treatment compsn. - contains capsicum, aconite, ballota, crataegus, drosera, grindelia, lobelia, passion flower and white willow
ATE235842T1 (en) ARTICLE FOR REDUCING THE SIDE FLOW OF A CIGARETTE
Kontos Role of hypercapnic acidosis in the local regulation of blood flow in skeletal muscle
Sutton et al. Randomized trial of brief individual treatment for smoking using nicotine chewing gum in a workplace setting.
Lee et al. Impact of e-cigarette vaping aerosol exposure in pregnancy on mTOR signaling in rat fetal hippocampus
JPH01141579A (en) Tea which is applicable as tobacco
Kreshovee Further observations on the effect of tobacco on epithelial tissues of vitamin-deficient mice
Maurer The argot of the underworld narcotic addict: Part II
Katoh Incidence of transient bacteremia following dental surgery--prophylactic use of cefuroxime, ceftriaxone or clindamycin
KR890015746A (en) How to treat AIDS cachexia with megestrol acetate
Moreira Alternative systems of tobacco consumption-oral manifestations and cessation effectiveness
EP0450253A1 (en) Means for breaking the habitual use of tobacco
JPS6468326A (en) Remedy for athlete's foot
Warburton The reality of the beneficial effects of nicotine.

Legal Events

Date Code Title Description
ST Notification of lapse